Table 3.
Frequency of oral antibiotic prescriptions by antibiotic groups and diagnoses
| Diagnoses | All visits | Visits with any antibiotic prescription and prescription rate (%) | Number (%) of visits with antibiotic prescriptions by antibiotic groups* | |||||||
| Penicillins | First/second cephem | Third cephem | Macrolides | Quinolones | ST | Tetracyclines | Other antibiotics | |||
| Miscellaneous bacterial infections | 45 061 | 20 429 (45.3) | 2969 (11.5) | 468 (1.8) | 7404 (28.7) | 7868 (30.5) | 5731 (22.2) | 181 (0.7) | 444 (1.7) | 728 (2.8) |
| STD | 14 051 | 3931 (28.0) | 86 (1.9) | 76 (1.7) | 836 (18.9) | 1515 (34.2) | 496 (11.2) | 14 (0.3) | 147 (3.3) | 1260 (28.4) |
| Bacterial pneumonia | 47 035 | 21 473 (45.7) | 916 (3.4) | 121 (0.5) | 5044 (18.9) | 8568 (32.2) | 11 236 (42.2) | 191 (0.7) | 238 (0.9) | 316 (1.2) |
| Abdominal infection | 9208 | 2077 (22.6) | 69 (3.2) | 29 (1.3) | 680 (31.1) | 142 (6.5) | 1086 (49.7) | ≤10 | ≤10 | 177 (8.1) |
| Orthopaedic infection | 1749 | 380 (21.7) | 36 (8.2) | 22 (5.0) | 225 (51.4) | 21 (4.8) | 93 (21.2) | ≤10 | 19 (4.3) | 22 (5.0) |
| Urinary tract infections | 97 948 | 37 674 (38.5) | 1195 (2.9) | 567 (1.4) | 14 735 (36.0) | 1998 (4.9) | 20 229 (49.5) | 429 (1.0) | 521 (1.3) | 1232 (3.0) |
| PID | 11 621 | 1763 (15.2) | 84 (4.6) | 26 (1.4) | 1127 (61.2) | 164 (8.9) | 167 (9.1) | ≤10 | ≤10 | 273 (14.8) |
| GI infections | 1 37 661 | 41 309 (30.0) | 2121 (4.6) | 264 (0.6) | 12 060 (26.0) | 8603 (18.6) | 13 206 (28.5) | 196 (0.4) | 232 (0.5) | 9680 (20.9) |
| Skin infections | 62 202 | 23 572 (37.9) | 1167 (4.6) | 1337 (5.3) | 15 311 (60.6) | 1975 (7.8) | 2848 (11.3) | 25 (0.1) | 997 (3.9) | 1615 (6.4) |
| Suppurative otitis media | 16 059 | 9958 (62.0) | 1566 (11.8) | 18 (0.1) | 5213 (39.1) | 1972 (14.8) | 3654 (27.4) | ≤10 | 92 (0.7) | 812 (6.1) |
| Pharyngitis | 1 46 508 | 78 469 (53.6) | 4372 (5.1) | 450 (0.5) | 35 958 (41.8) | 27 454 (31.9) | 16 387 (19.1) | 121 (0.1) | 301 (0.3) | 976 (1.1) |
| Sinusitis | 80 078 | 45 456 (56.8) | 3654 (6.9) | 481 (0.9) | 15 282 (28.8) | 20 677 (39.0) | 11 441 (21.6) | ≤10 | 779 (1.5) | 766 (1.4) |
| Bronchitis with COPD | 6832 | 4313 (63.1) | 208 (4.1) | 14 (0.3) | 912 (17.8) | 2178 (42.5) | 1762 (34.3) | 28 (0.5) | 11 (0.2) | 17 (0.3) |
| Acne | 6939 | 2030 (29.3) | ≤10 | 32 (1.5) | 174 (8.3) | 739 (35.2) | 41 (2.0) | ≤10 | 1050 (50.0) | 62 (3.0) |
| Non-bacterial GI infections | 1215 | 116 (9.5) | ≤10 | ≤10 | 42 (33.1) | 38 (29.9) | 33 (26.0) | ≤10 | ≤10 | 14 (11.0) |
| Non-suppurative otitis media | 2807 | 888 (31.6) | 63 (5.8) | ≤10 | 384 (35.5) | 481 (44.5) | 128 (11.8) | ≤10 | ≤10 | 26 (2.4) |
| Viral URI | 2 74 441 | 96 989 (35.3) | 4839 (4.6) | 825 (0.8) | 44 475 (42.1) | 37 001 (35.0) | 16 941 (16.0) | 160 (0.2) | 790 (0.7) | 601 (0.6) |
| Influenza | 22 868 | 8665 (37.9) | 296 (3.1) | 74 (0.8) | 3030 (31.9) | 3934 (41.5) | 2040 (21.5) | ≤10 | 47 (0.5) | 69 (0.7) |
| Viral pneumonia | 15 | ≤10 | ≤10 | ≤10 | ≤10 | ≤10 | ≤10 | ≤10 | ≤10 | ≤10 |
| Bronchitis without COPD | 89 479 | 47 248 (52.8) | 1509 (3.0) | 332 (0.7) | 14 521 (28.5) | 22 779 (44.8) | 11 078 (21.8) | 58 (0.1) | 250 (0.5) | 346 (0.7) |
| Non-infectious diarrhoea | 1597 | 50 (3.1) | ≤10 | ≤10 | ≤10 | 19 (55.9) | 15 (44.1) | ≤10 | ≤10 | ≤10 |
| Fever | 2908 | 438 (15.1) | 20 (4.3) | ≤10 | 190 (40.5) | 103 (22.0) | 156 (33.3) | ≤10 | ≤10 | ≤10 |
*Antibiotics were coded according to ATC codes: Penicillins, J01C; First-generation cephalosporins, J01DB; Second-generation cephalosporins, J01DC; Third-generation cephalosporins, J01DD; Macrolides, J01FA; Quinolones, J01M; Sulfonamides and trimethoprim, J01E; Tetracyclines, J01A; Other antibiotics, J01B, J01DH, J01DI, J01FF, J01G and J01X.
ATC, Anatomical Therapeutic Chemical; COPD, chronic obstructive pulmonary disease; First/second cephem, first/second-generation cephalosporins; GI infections, gastrointestinal infections; PID, pelvic inflammatory diseases; Skin infections, Skin, cutaneous and mucosal infections; ST, sulfonamides and trimethoprim; STD, sexual transmitted diseases; third cephem, third-generation cephalosporins; URI, upper respiratory infections.